We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Infected Blood Cells' Electrical Properties Indicate Early Malaria

By LabMedica International staff writers
Posted on 27 Aug 2013
A new prototype device recognizes electrical properties of Plasmodium falciparum-infected cells as signatures of disease.

Scientists examined whether it was possible to use electrical impedance as a diagnostic signal for malaria. More...
Several types of infection, including malaria, alter a cell’s impedance, a measure of electrical resistance across the cell membrane. Previous studies had demonstrated electrical changes in later-stage infected cells, but it was not clear that cells that had reached only the ring stage of infection would exhibit electrical changes.

A microfluidic device was constructed that takes a drop of blood and streams it across an electrode that measures a signal differentiating infected cells from uninfected cells. The work, which recognizes ring-stage Plasmodium falciparum infected blood cells, was published August 8, 2003, in the journal Lab On A Chip, could be the first step toward a field-ready, low-cost, portable malaria-detection device.

The microfluidic device built by the scientists was capable of measuring the magnitude and phase of the electrical impedance of individual cells. The device is essentially a cell-counting device, similar in approach to other low-cost, portable devices being developed to diagnose illnesses such as HIV.

“Ultimately the goal would be to create a postage stamp-sized device with integrated electronics that can detect if a person has malaria and at what stage,” said Anantha Chandrakasan, the Joseph F. and Nancy P. Keithley professor of electrical engineering and a principal investigator at Massachusetts Institute of Technology's (MIT; Cambridge, MA, USA) Microsystems Technology Laboratories (MTL) who specializes in developing low-power electronic devices. Similar diagnostics may be applicable to other infections and diseases.

In tests of cells of four cell types—uninfected cells and infected cells at the ring stage, trophozoite, and schizont stages—the device detected small differences in measures of magnitude and seemingly random differences in phase, but not quite enough to definitively differentiate among stages.

However, by mathematically combining the measures into an index called delta, the differences between uninfected cells and all three stages became clear. “It’s much more significant,” said corresponding author Ming Dao, a principal research scientist in the Nanomechanics Laboratory. “It’s a more holistic approach. By using all of the information we can measure, we can detect the differentiating signals much more clearly.”

Malaria is a curable disease, but diagnosis remains a challenge. This ability to discern the circulating parasite’s stage from a drop of blood opens the possibility of building a device that could be used to rapidly diagnose malarial infection in places where laboratories and skilled medical personnel are scarce.

Related Links:

Massachusetts Institute of Technology's
Microsystems Technology Laboratories



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.